Search results for "Vaccination"
Fighting COVID-19 vaccine fallacies with facts
This issue addressed COVID-19 vaccination and integrating oral health into primary care.
https://immattersacp.org/archives/2021/11/fighting-covid-19-vaccine-fallacies-with-facts.htm
1 Nov 2021
CDC recommendations on COVID-19 vaccine boosters, new data on vaccine effectiveness
Several groups in the U.S. are now eligible to receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine at least six months after completing the initial two-dose series.
https://immattersacp.org/weekly/archives/2021/09/28/1.htm
28 Sep 2021
Preparing today for tomorrow's potential pandemic
We all have a responsibility to reflect on our experiences with COVID-19 to identify both the good and the bad, assess the current state of pandemic preparedness, and implement a comprehensive plan.
https://immattersacp.org/archives/2023/09/preparing-today-for-tomorrows-potential-pandemic.htm
1 Sep 2023
Flu vaccination is rarely associated with subdeltoid bursitis, study finds
Clinicians could benefit from an injection technique “tune-up” in needle placement and needle length, an editorial suggested.
https://immattersacp.org/weekly/archives/2020/06/23/6.htm
23 Jun 2020
Anaphylaxis appears rare with COVID-19 vaccine, alternative administration strategies considered
The CDC's monitoring system found low rates of anaphylaxis after a first dose of the Pfizer-BioNTech COVID-19 vaccine, peer-reviewed data were published on the Moderna vaccine, and alternate vaccine administration strategies were evaluated.
https://immattersacp.org/weekly/archives/2021/01/12/2.htm
12 Jan 2021
Tirzepatide for weight management, at-home STI tests
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/01/tirzepatide-for-weight-management-at-home-sti-tests.htm
1 Jan 2024
Advice on monoclonal antibodies; new data on long-term COVID-19 symptoms, vaccine efficacy
The NIH offered guidance on prioritization when monoclonal antibodies can't be given to all eligible patients. Two studies looked at patients with persistent COVID-19 symptoms, and other research confirmed the safety and effectiveness of the vaccines, even with the delta variant.
https://immattersacp.org/weekly/archives/2021/09/14/2.htm
14 Sep 2021
Looking ahead at the past
ACP membership inspires through its principles, opportunities, and relevance.
https://immattersacp.org/archives/2024/01/looking-ahead-at-the-past.htm
1 Jan 2024
New data on COVID-19 vaccines' effectiveness over time, boosters, barriers to uptake
Multiple recent studies assessed the effectiveness of the COVID-19 vaccines at different time intervals after vaccination, while others looked at the impact of booster shots. Results of a survey suggested that racial differences in vaccine uptake may be attributable to social barriers.
https://immattersacp.org/weekly/archives/2021/12/07/1.htm
7 Dec 2021
Fourth vaccine dose 62% effective against severe COVID-19 in month after receipt
Retrospective data from Israel showed that in people ages 60 years and older, an additional booster dose of the Pfizer-BioNTech COVID-19 vaccine was 55% effective against symptomatic disease and 68% effective against hospitalization.
https://immattersacp.org/weekly/archives/2022/04/19/4.htm
19 Apr 2022